Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,184 | 8,202 | 1,785 | 41 | 65 |
| TOTAL | $39,036 | $8,631 | $2,010 | $144 | $89 |
| Non-Current Assets | |||||
| PPE Net | 328 | 45 | 47 | 26 | 32 |
| Other Non-Current Assets | 178 | 60 | 60 | 256 | 63 |
| TOTAL | $506 | $105 | $107 | $282 | $95 |
| Total Assets | $39,542 | $8,736 | $2,117 | $425 | $184 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 280 | N/A | 150 | N/A |
| Accounts payable and accrued liabilities | 1,487 | 765 | 825 | 695 | 318 |
| Accrued Expenses | 1,895 | 1,166 | 313 | 49 | 23 |
| Other current liabilities | N/A | N/A | N/A | 32 | N/A |
| TOTAL | $3,382 | $2,211 | $1,138 | $925 | $340 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,925 | 0 |
| TOTAL | $68 | $13 | $20 | $1,954 | $19 |
| Total Liabilities | $3,450 | $2,224 | $1,158 | $2,879 | $360 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,138 | 9,899 | 43,183 | 34,278 | 5,500 |
| Common Shares | 11 | 6 | 2 | 27 | 18 |
| Retained earnings | -54,344 | -26,728 | -15,844 | -6,395 | -2,925 |
| Other shareholders' equity | 2 | -1 | 0 | 0 | 0 |
| TOTAL | $36,092 | $6,512 | $959 | $-2,454 | $-176 |
| Total Liabilities And Equity | $39,542 | $8,736 | $2,117 | $426 | $184 |